EXC Q1 2026 Earnings Slight EPS Beat Bolsters Utilitys Steady Outlook Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise ICON Q4 2025 Earnings EPS Miss Highlights Operational Challenges MSFT Q1 2026 Earnings Solid EPS Beat Offsets Modest Revenue Headwinds iBio Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 33 KR Q1 2026 Earnings EPS Beats Estimates Stock Declines 4 Despite Strong Core Performance